No beneficial effect of two-layer storage compared with UW-storage on human islet isolation and transplantation.

Journal article

BACKGROUND: Shipment of pancreata between distant centers is frequently associated with prolonged cold ischemia time (CIT) that leads to poorer outcomes for islet transplantation. Clinical pilot trials have indicated that oxygenation of explanted human pancreata utilizing the two-layer method (TLM) allows the use of marginal donor pancreata for islet transplantation. The present study aimed to clarify whether TLM enhances the ischemic tolerance of human pancreata. METHODS: We analyzed retrospectively the outcome of 200 human islet isolations performed after TLM preservation or storage in University of Wisconsin solution (UWS). RESULTS: Donor characteristics and digestion parameters did not vary significantly between TLM-preserved and UWS-stored pancreata. No differences were observed between experimental groups with regard to islet yield, purity, or dynamic glucose stimulation index after either short or prolonged CIT. However, CIT and stimulation index were negatively correlated in each experimental group. The isolation outcome in donors aged > or =60 years was not increased after TLM preservation when compared to UWS storage. No effect was observed regarding islet posttransplant function in recipients with established kidney grafts. CONCLUSIONS: The present study suggests that the ischemic tolerance of human pancreata cannot be extended by TLM preservation. In addition, TLM does not seem to improve the isolation outcome for pancreata from elderly donors.

Authors: Caballero-Corbalán, J; Eich, T; Lundgren, T; Foss, A; Felldin, M

• Journal: Transplantation
• Volume: 84
• Issue: 7
• Pages: 864-869
• Publication date: 2007-10-01
• DOI: 10.1097/01.tp.0000284584.60600.ab
• EISSN: 1534-6080
• ISSN: 0041-1337
• Language: English
• Keywords: Retrospective Studies; Adult; Pilot Projects; Female; Islets of Langerhans Transplantation; Male; Time Factors; Organ Preservation; Specimen Handling; Treatment Outcome; Aged; Humans; Adenosine; Pancreas; Organ Preservation Solutions; Islets of Langerhans; Allopurinol; Glutathione; Middle Aged; Raffinose; Insulin